Higuchi Ryotaro, Streilein J Wayne
Schepens Eye Research Institute and Department of Ophthalmology, 20 Staniford Street, Harvard Medical School, Boston, MA 02114, USA.
Invest Ophthalmol Vis Sci. 2003 Jan;44(1):175-82. doi: 10.1167/iovs.02-0050.
To determine the immunopathogenesis of delayed orthotopic corneal xenograft rejection in mice deficient in the xenoreactive CD4+ T cells that mediate acute rejection.
CB.17 SCID and BALB/c mice were used as recipients of orthotopic cornea grafts obtained from strain 13 guinea pigs. Before transplantation, SCID recipients, which do not normally reject guinea pig cornea grafts, were reconstituted with spleen cells (whole, CD4-depleted, CD4/CD8-depleted) or purified CD8+ T cells from normal BALB/c donors. Graft survival was assessed by clinical examination, and median survival times (MST) were calculated. Lymphocytes from mice that rejected guinea pig cornea grafts were analyzed in vitro for their capacity to respond to guinea pig xenoantigens and to lyse guinea pig target cells.
SCID mice reconstituted with whole spleen cells from BALB/c donors rejected guinea pig corneas with a vigor identical with that of normal BALB/c mice (MST = 15 and 14 days, respectively), whereas SCID mice reconstituted with CD4-depleted BALB/c spleen cells rejected guinea pig corneas in a delayed fashion (MST = 27 days), as did SCID mice reconstituted with purified CD8+ T cells from BALB/c donors. Although CD8+ T cells from rejector mice failed to lyse guinea pig target cells in vitro, the T cells proliferated and secreted IFN-gamma in response to in vitro stimulation with guinea pig xenoantigens.
Guinea pig cornea xenografts that avoid acute rejection in CD4+ T cell-depleted mice are vulnerable to rejection by CD8+ T cells. Effector CD8+ T cells destroy corneal xenografts through release of proinflammatory mediators (IFN-gamma) rather than by cytotoxicity.
确定在介导急性排斥反应的异种反应性CD4+ T细胞缺陷的小鼠中,延迟性原位角膜异种移植排斥反应的免疫发病机制。
将CB.17 SCID和BALB/c小鼠作为从13品系豚鼠获得的原位角膜移植物的受体。移植前,通常不会排斥豚鼠角膜移植物的SCID受体用来自正常BALB/c供体的脾细胞(全脾细胞、去除CD4的脾细胞、去除CD4/CD8的脾细胞)或纯化的CD8+ T细胞进行重建。通过临床检查评估移植物存活情况,并计算中位存活时间(MST)。对排斥豚鼠角膜移植物的小鼠的淋巴细胞进行体外分析,以检测其对豚鼠异种抗原的反应能力和裂解豚鼠靶细胞的能力。
用BALB/c供体的全脾细胞重建的SCID小鼠排斥豚鼠角膜的活力与正常BALB/c小鼠相同(MST分别为15天和14天),而用去除CD4的BALB/c脾细胞重建的SCID小鼠以延迟方式排斥豚鼠角膜(MST = 27天),用来自BALB/c供体的纯化CD8+ T细胞重建的SCID小鼠也是如此。尽管来自排斥小鼠的CD8+ T细胞在体外未能裂解豚鼠靶细胞,但这些T细胞在受到豚鼠异种抗原的体外刺激时会增殖并分泌IFN-γ。
在去除CD4+ T细胞的小鼠中避免急性排斥反应的豚鼠角膜异种移植物易受CD8+ T细胞排斥。效应性CD8+ T细胞通过释放促炎介质(IFN-γ)而非细胞毒性作用破坏角膜异种移植物。